Results 11 to 20 of about 12,294 (206)

Shark IgNAR: The Next Broad Application Antibody in Clinical Diagnoses and Tumor Therapies?

open access: yesMarine Drugs, 2023
Antibodies represent a relatively mature detection means and serve as therapeutic drug carriers in the clinical diagnosis and treatment of cancer—among which monoclonal antibodies (mAbs) currently occupy a dominant position.
Xiaofeng Jiang   +5 more
doaj   +1 more source

Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status

open access: yesCell Host and Microbe, 2022
Both SARS-CoV-2 infections and COVID-19 vaccines elicit memory T cell responses. Here, we report the development of 2 pools of experimentally defined SARS-CoV-2 T cell epitopes that, in combination with spike, were used to discriminate 4 groups of ...
E. Yu   +19 more
semanticscholar   +1 more source

Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment

open access: yesInternational Journal of Molecular Sciences, 2021
Hepatocellular carcinoma (HCC) exerts huge effects on the health burden of the world because of its high mortality and poor prognosis. HCC is often clinically detected late in patients.
Mengtao Xing   +4 more
semanticscholar   +1 more source

Capture ELISA for KPC Detection in Gram-Negative Bacilli: Development and Standardisation

open access: yesMicroorganisms, 2023
The detection of KPC-type carbapenemases is necessary for guiding appropriate antibiotic therapy and the implementation of antimicrobial stewardship and infection control measures.
André Valencio   +6 more
doaj   +1 more source

Comparison of Immunodiagnostic Assays for the Rapid Diagnosis of Coccidioidomycosis in Dogs

open access: yesJournal of Fungi, 2022
Coccidioidomycosis is a disease caused by the dimorphic fungi Coccidioides spp., which affects humans and a variety of animal species, including domestic dogs.
D. Cáceres, M. Lindsley
semanticscholar   +1 more source

SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study

open access: yesViruses, 2021
Humoral immunity has emerged as a vital immune component against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nevertheless, a subset of recovered Coronavirus Disease-2019 (COVID-19) paucisymptomatic/asymptomatic individuals do not ...
K. Belogiannis   +12 more
semanticscholar   +1 more source

Immunogenic Proteins of Group B Streptococcus—Potential Antigens in Immunodiagnostic Assay for GBS Detection

open access: yesPathogens, 2021
Streptococcus agalactiae (Group B Streptococcus, GBS) is an opportunistic pathogen, which asymptomatically colonizes the gastrointestinal and genitourinary tract of up to one third of healthy adults.
Anna Dobrut, M. Brzychczy-Włoch
semanticscholar   +1 more source

Interferon Gamma and Soluble MICA as A New Biomarker for Immunological Severity Detection in HIV Infected Patients Undergoing Retroviral Therapy

open access: yesJournal of Health Science and Medical Research (JHSMR), 2022
Objective: Variations in immune responses to viral particles and antiretroviral drugs show interference of the cluster of differentiation number 4 T cell monitoring methods, leading to an inaccurate evaluation for human immunodeficiency virus infected ...
Sarayot Rareongjai   +3 more
doaj   +1 more source

Towards tumor immunodiagnostics [PDF]

open access: yesAnnals of Translational Medicine, 2016
Immunodiagnostic markers applicable on tissue or cytologic material may be prognostic or predictive of response to immunomodulatory drugs and may also be classified according to whether they are cell-specific or tumor-tissue-specific. Cell-specific markers are evaluated under the microscope as (I) morphological, corresponding to the assessment of tumor
Helen, Kourea, Vassiliki, Kotoula
openaire   +2 more sources

Immunodiagnosis — the promise of personalized immunotherapy

open access: yesFrontiers in Immunology, 2023
Immunotherapy showed remarkable efficacy in several cancer types. However, the majority of patients do not benefit from immunotherapy. Evaluating tumor heterogeneity and immune status before treatment is key to identifying patients that are more likely ...
Renjie Wang   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy